![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CYTH1 |
Gene summary for CYTH1 |
![]() |
Gene information | Species | Human | Gene symbol | CYTH1 | Gene ID | 9267 |
Gene name | cytohesin 1 | |
Gene Alias | B2-1 | |
Cytomap | 17q25.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q15438 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9267 | CYTH1 | CA_HPV_1 | Human | Cervix | CC | 1.21e-02 | 2.43e-01 | 0.0264 |
9267 | CYTH1 | CCI_2 | Human | Cervix | CC | 2.02e-03 | 7.76e-01 | 0.5249 |
9267 | CYTH1 | CCI_3 | Human | Cervix | CC | 3.72e-07 | 8.23e-01 | 0.516 |
9267 | CYTH1 | AEH-subject1 | Human | Endometrium | AEH | 1.35e-14 | 4.75e-01 | -0.3059 |
9267 | CYTH1 | AEH-subject2 | Human | Endometrium | AEH | 3.24e-03 | 2.70e-01 | -0.2525 |
9267 | CYTH1 | AEH-subject3 | Human | Endometrium | AEH | 5.30e-03 | 3.16e-01 | -0.2576 |
9267 | CYTH1 | AEH-subject4 | Human | Endometrium | AEH | 9.62e-23 | 7.01e-01 | -0.2657 |
9267 | CYTH1 | AEH-subject5 | Human | Endometrium | AEH | 1.92e-31 | 8.59e-01 | -0.2953 |
9267 | CYTH1 | EEC-subject1 | Human | Endometrium | EEC | 1.92e-15 | 5.80e-01 | -0.2682 |
9267 | CYTH1 | EEC-subject2 | Human | Endometrium | EEC | 6.27e-07 | 3.31e-01 | -0.2607 |
9267 | CYTH1 | EEC-subject3 | Human | Endometrium | EEC | 7.64e-03 | 3.25e-01 | -0.2525 |
9267 | CYTH1 | EEC-subject4 | Human | Endometrium | EEC | 5.65e-12 | 5.38e-01 | -0.2571 |
9267 | CYTH1 | EEC-subject5 | Human | Endometrium | EEC | 1.12e-13 | 5.16e-01 | -0.249 |
9267 | CYTH1 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 9.84e-03 | -1.16e-01 | -0.1869 |
9267 | CYTH1 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 1.63e-02 | 3.13e-02 | -0.1875 |
9267 | CYTH1 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 6.34e-04 | -9.90e-02 | -0.1883 |
9267 | CYTH1 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 4.99e-06 | -7.50e-02 | -0.1917 |
9267 | CYTH1 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 2.45e-03 | -6.86e-02 | -0.1916 |
9267 | CYTH1 | LZE4T | Human | Esophagus | ESCC | 1.20e-09 | 2.95e-01 | 0.0811 |
9267 | CYTH1 | LZE5T | Human | Esophagus | ESCC | 1.69e-08 | 2.53e-01 | 0.0514 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00071639 | Cervix | CC | establishment or maintenance of cell polarity | 63/2311 | 218/18723 | 4.25e-11 | 8.76e-09 | 63 |
GO:00510566 | Cervix | CC | regulation of small GTPase mediated signal transduction | 75/2311 | 302/18723 | 1.54e-09 | 1.74e-07 | 75 |
GO:00072656 | Cervix | CC | Ras protein signal transduction | 79/2311 | 337/18723 | 9.49e-09 | 7.77e-07 | 79 |
GO:00300108 | Cervix | CC | establishment of cell polarity | 42/2311 | 143/18723 | 4.30e-08 | 2.62e-06 | 42 |
GO:00465785 | Cervix | CC | regulation of Ras protein signal transduction | 44/2311 | 189/18723 | 2.05e-05 | 3.73e-04 | 44 |
GO:00901627 | Cervix | CC | establishment of epithelial cell polarity | 11/2311 | 31/18723 | 7.87e-04 | 6.96e-03 | 11 |
GO:000716310 | Endometrium | AEH | establishment or maintenance of cell polarity | 54/2100 | 218/18723 | 1.30e-08 | 8.47e-07 | 54 |
GO:00300109 | Endometrium | AEH | establishment of cell polarity | 36/2100 | 143/18723 | 2.19e-06 | 6.49e-05 | 36 |
GO:00510567 | Endometrium | AEH | regulation of small GTPase mediated signal transduction | 59/2100 | 302/18723 | 1.43e-05 | 3.03e-04 | 59 |
GO:00072657 | Endometrium | AEH | Ras protein signal transduction | 63/2100 | 337/18723 | 3.09e-05 | 5.66e-04 | 63 |
GO:00465786 | Endometrium | AEH | regulation of Ras protein signal transduction | 36/2100 | 189/18723 | 1.01e-03 | 8.97e-03 | 36 |
GO:00901628 | Endometrium | AEH | establishment of epithelial cell polarity | 10/2100 | 31/18723 | 1.48e-03 | 1.23e-02 | 10 |
GO:000716315 | Endometrium | EEC | establishment or maintenance of cell polarity | 56/2168 | 218/18723 | 5.41e-09 | 3.57e-07 | 56 |
GO:003001014 | Endometrium | EEC | establishment of cell polarity | 36/2168 | 143/18723 | 4.57e-06 | 1.15e-04 | 36 |
GO:005105612 | Endometrium | EEC | regulation of small GTPase mediated signal transduction | 61/2168 | 302/18723 | 9.42e-06 | 2.08e-04 | 61 |
GO:000726513 | Endometrium | EEC | Ras protein signal transduction | 64/2168 | 337/18723 | 4.31e-05 | 7.10e-04 | 64 |
GO:004657813 | Endometrium | EEC | regulation of Ras protein signal transduction | 37/2168 | 189/18723 | 9.23e-04 | 8.32e-03 | 37 |
GO:009016213 | Endometrium | EEC | establishment of epithelial cell polarity | 10/2168 | 31/18723 | 1.89e-03 | 1.45e-02 | 10 |
GO:000716320 | Esophagus | ESCC | establishment or maintenance of cell polarity | 143/8552 | 218/18723 | 2.05e-09 | 4.65e-08 | 143 |
GO:000726510 | Esophagus | ESCC | Ras protein signal transduction | 201/8552 | 337/18723 | 1.44e-07 | 2.30e-06 | 201 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0513245 | Oral cavity | EOLP | Salmonella infection | 78/1218 | 249/8465 | 3.66e-12 | 2.37e-10 | 1.40e-10 | 78 |
hsa0414442 | Oral cavity | EOLP | Endocytosis | 71/1218 | 251/8465 | 5.28e-09 | 8.97e-08 | 5.29e-08 | 71 |
hsa0513045 | Oral cavity | EOLP | Pathogenic Escherichia coli infection | 54/1218 | 197/8465 | 1.10e-06 | 9.96e-06 | 5.87e-06 | 54 |
hsa0513146 | Oral cavity | EOLP | Shigellosis | 61/1218 | 247/8465 | 9.48e-06 | 5.47e-05 | 3.23e-05 | 61 |
hsa040722 | Oral cavity | EOLP | Phospholipase D signaling pathway | 31/1218 | 148/8465 | 1.82e-02 | 4.67e-02 | 2.76e-02 | 31 |
hsa0513255 | Oral cavity | EOLP | Salmonella infection | 78/1218 | 249/8465 | 3.66e-12 | 2.37e-10 | 1.40e-10 | 78 |
hsa0414452 | Oral cavity | EOLP | Endocytosis | 71/1218 | 251/8465 | 5.28e-09 | 8.97e-08 | 5.29e-08 | 71 |
hsa0513055 | Oral cavity | EOLP | Pathogenic Escherichia coli infection | 54/1218 | 197/8465 | 1.10e-06 | 9.96e-06 | 5.87e-06 | 54 |
hsa0513156 | Oral cavity | EOLP | Shigellosis | 61/1218 | 247/8465 | 9.48e-06 | 5.47e-05 | 3.23e-05 | 61 |
hsa0407211 | Oral cavity | EOLP | Phospholipase D signaling pathway | 31/1218 | 148/8465 | 1.82e-02 | 4.67e-02 | 2.76e-02 | 31 |
hsa0513263 | Oral cavity | NEOLP | Salmonella infection | 67/1112 | 249/8465 | 3.05e-09 | 7.46e-08 | 4.69e-08 | 67 |
hsa0513063 | Oral cavity | NEOLP | Pathogenic Escherichia coli infection | 55/1112 | 197/8465 | 2.04e-08 | 4.32e-07 | 2.72e-07 | 55 |
hsa0513163 | Oral cavity | NEOLP | Shigellosis | 62/1112 | 247/8465 | 1.93e-07 | 2.79e-06 | 1.75e-06 | 62 |
hsa0414461 | Oral cavity | NEOLP | Endocytosis | 62/1112 | 251/8465 | 3.56e-07 | 4.92e-06 | 3.09e-06 | 62 |
hsa0513273 | Oral cavity | NEOLP | Salmonella infection | 67/1112 | 249/8465 | 3.05e-09 | 7.46e-08 | 4.69e-08 | 67 |
hsa0513073 | Oral cavity | NEOLP | Pathogenic Escherichia coli infection | 55/1112 | 197/8465 | 2.04e-08 | 4.32e-07 | 2.72e-07 | 55 |
hsa0513173 | Oral cavity | NEOLP | Shigellosis | 62/1112 | 247/8465 | 1.93e-07 | 2.79e-06 | 1.75e-06 | 62 |
hsa0414471 | Oral cavity | NEOLP | Endocytosis | 62/1112 | 251/8465 | 3.56e-07 | 4.92e-06 | 3.09e-06 | 62 |
hsa0513228 | Prostate | BPH | Salmonella infection | 99/1718 | 249/8465 | 7.26e-13 | 1.50e-11 | 9.27e-12 | 99 |
hsa0513128 | Prostate | BPH | Shigellosis | 94/1718 | 247/8465 | 5.19e-11 | 9.51e-10 | 5.89e-10 | 94 |
Page: 1 2 3 4 5 6 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CYTH1 | insertion | Frame_Shift_Ins | novel | c.1142_1143insGTTTGTTTGTTTTTGCC | p.Phe381LeufsTer65 | p.F381Lfs*65 | Q15438 | protein_coding | TCGA-A8-A09C-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
CYTH1 | deletion | In_Frame_Del | c.1093_1095delNNN | p.Lys365del | p.K365del | Q15438 | protein_coding | TCGA-BH-A18K-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |||
CYTH1 | SNV | Missense_Mutation | novel | c.52C>G | p.Gln18Glu | p.Q18E | Q15438 | protein_coding | tolerated(1) | benign(0) | TCGA-EA-A43B-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CYTH1 | SNV | Missense_Mutation | c.973G>C | p.Glu325Gln | p.E325Q | Q15438 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-JX-A3Q0-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | |
CYTH1 | SNV | Missense_Mutation | c.215N>C | p.Lys72Thr | p.K72T | Q15438 | protein_coding | deleterious(0) | possibly_damaging(0.887) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CYTH1 | SNV | Missense_Mutation | c.734A>C | p.Lys245Thr | p.K245T | Q15438 | protein_coding | deleterious(0.01) | benign(0.245) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
CYTH1 | SNV | Missense_Mutation | novel | c.554N>A | p.Thr185Asn | p.T185N | Q15438 | protein_coding | deleterious(0) | probably_damaging(0.975) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CYTH1 | SNV | Missense_Mutation | rs778692007 | c.811G>A | p.Gly271Arg | p.G271R | Q15438 | protein_coding | tolerated(0.2) | possibly_damaging(0.807) | TCGA-DY-A1H8-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CYTH1 | insertion | Frame_Shift_Ins | novel | c.639dupG | p.Phe214ValfsTer10 | p.F214Vfs*10 | Q15438 | protein_coding | TCGA-AA-3860-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | folinic | CR | ||
CYTH1 | insertion | Frame_Shift_Ins | novel | c.728_729insTAAGTCTCAG | p.Phe244LysfsTer5 | p.F244Kfs*5 | Q15438 | protein_coding | TCGA-AM-5820-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |